The RESET Clinical Trial: SPRINTĀ® Peripheral Nerve Stimulation for the Treatment of Back Pain
Purpose
The purpose of this study is to compare standard of care treatments for back pain to electrical stimulation. Stimulation is delivering small amounts of electricity to the nerves in your low back. This study will use a device called the SPRINT Peripheral Nerve Stimulation (PNS) System. The device is cleared by the FDA for up to 60 days of use for the relief of chronic or acute pain (including back pain)
Conditions
- Low Back Pain
- Back Pain
Eligibility
- Eligible Ages
- Between 21 Years and 75 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Chronic low back pain
Exclusion Criteria
- Body Mass Index (BMI) > 40 - Prior lumbar surgery - Implanted electronic device - Pregnant
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Active Comparator Group 1: Peripheral Nerve Stimulation (PNS) |
Subjects in Group 1 will have leads placed in their lower back. These subjects will then use the SPRINT Peripheral Nerve Stimulation (PNS) System and will receive electrical stimulation for 8 weeks. |
|
Active Comparator Group 2: Standard Interventional Management (Standard of Care) |
Subjects in Group 2 will receive the standard of care. Group 2 subjects may be able to crossover to receive PNS after 12 months from start of treatment (Visit 16). |
|
Recruiting Locations
More Details
- NCT ID
- NCT04246281
- Status
- Active, not recruiting
- Sponsor
- SPR Therapeutics, Inc.